The plethora of treatment options available for localized prostate cancer can make the patient's decision regarding which therapy to undergo a difficult one. A recent study has investigated the effect of using a decision aid to provide patients with enough information to make an informed decision about their therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Jang, T. L. et al. Physician visits prior to treatment for clinically localized prostate cancer. Arch. Intern. Med. 170, 440–450 (2010).
van Tol-Geerdink, J. J. et al. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized control trial of usual care vs decision aid. BJU Int. http://dx.doi.org/10.1111/j.1464-410X.2012.11402.x.
Zelefsky, M. J. et al. Secondary cancers after intensity modulated radiotherapy, brachytherapy and radical prostatectomy, for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention. BJU Int. http://dx.doi.org/10.1111/j.1464-410X.2012.11385.x.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Zelefsky, M. Challenges in selecting the optimal therapy. Nat Rev Urol 9, 674–676 (2012). https://doi.org/10.1038/nrurol.2012.193
Published:
Issue date:
DOI: https://doi.org/10.1038/nrurol.2012.193
